Skip to main content
OpenTrials

Clinical trial condition

Incurable Platinum Refractory Germ Cell Tumors

Explore clinical trials studying Incurable Platinum Refractory Germ Cell Tumors. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Incurable Platinum Refractory Germ Cell Tumors trial results

Completed

A Study to Assess the Safety and Efficacy of ASP1650, a Monoclonal Antibody Targeting Claudin 6 (CLDN6), in Male Subjects With Incurable Platinum Refractory Germ Cell Tumors

NCT03760081

Conditions
Incurable Platinum Refractory Germ Cell Tumors, Neoplasms, Tumors
Locations
  • Indiana University Simon Cancer Center Indianapolis, Indiana, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • Abramson Cancer Center University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions